The nonsurgical management of vascular lesions

Facial Plastic Surgery Clinics

Volumn 9, Issue 4, 2001, Pages 601-608

  Adams, Denise M ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA2A INTERFERON; ALPHA2B INTERFERON; AMINOCAPROIC ACID; ANGIOGENESIS INHIBITOR; BLOOD CLOTTING FACTOR 10; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DIPYRIDAMOLE; FIBRIN; INTERFERON; LOW MOLECULAR WEIGHT HEPARIN; ORAPRED; PEDIAPRED; PREDNISOLONE; PREDNISOLONE SODIUM PHOSPHATE; PREDNISONE; RANITIDINE; TRANEXAMIC ACID; VINCRISTINE;

ARTICLE; CLINICAL FEATURE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG FORMULATION; DRUG MECHANISM; DRUG MEGADOSE; HEMANGIOMA; HUMAN; HYDROTHERAPY; HYPERGLYCEMIA; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; INFANT; MEDICAL ASSESSMENT; MYOSITIS; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PHYSIOTHERAPY; PRACTICE GUIDELINE; STOMACH ULCER; TREATMENT FAILURE; VASCULAR LESION;

ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; FACIAL NEOPLASMS; GLUCOCORTICOIDS; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTERFERONS; SKIN NEOPLASMS; VINCRISTINE;

EID: 0035694717     PISSN: 10647406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords
2. Angiomas of the parotid region: Results of corticoid therapy in 10 treated cases and critical review of the treatments used up until the present time
3. Spastic diplegia as a complication of interferon alpha 2a treatment of hemangiomas of infancy
4. Corticosteroid treatment of cutaneous hemangiomas: How effective? A report on 24 children
5. Treatment of Kasabach-Merritt syndrome by embolization of a giant liver hemangioma
6. Role of low-dose radiotherapy in the multimodal treatment of Kasabach-Merritt syndrome
7. Treatment of cavernous hemangioma with vincristine
8. Complications of systemic corticosteroid therapy for problematic hemangioma
9. Prednisone therapy in the management of large hemangiomas in infants and children
10. Successful treatment of infantile hemangiomas with interferon-±-2b
11. Diagnosis and management of massive hepatic hemangiomas in childhood
12. Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemia
13. Treatment of periocular capillary hemangioma with topical clobetasol propionate
14. Vascular malformations and hemangiomas: A practical approach in a multidisciplinary clinic
15. Toxicity profile of interferon alfa-2b in children: A prospective evaluation
16. A UK Consensus Group on management of glucocorticoid induced osteoporosis: An update
17. Extensive pure venous malformations in the upper or lower limb: A review of 27 cases
18. Vascular tumors and vascular malformations (new issues)
19. Residual lesions after Kasabach-Merritt phenomenon in 41 patients
20. Management of alarming hemangiomas in infancy: A review of 25 cases
21. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas
22. Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes
23. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy
24. Vascular anomalies: A primer for pediatricians
25. Guidelines of care for hemangiomas of infancy
26. Phace syndrome: The association of posterior fossa brain malformations, hemangiomas, arterial anolmalies, coarctation of the aorta and cardiac defects, and eye abnormalities
27. Vincristine revisited
28. Sacral hemangiomas and multiple congenital anomalies
29. Kasabach-Merritt phenomenon: A retrospective study of treatment with vincristine
30. Tranexamic acid in the treatment of Kasabach-Merritt syndrome in infants
31. Studies on an intermittent corticosteroid dosage regimen
32. Kasabach-Merritt syndrome with profound platelet support
33. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas
34. Kasabach-Merritt syndrome-associated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine and actinomycin D
35. Cyclophosphamide therapy in life-threatening vascular tumors
36. Clinical pearl: Use of self-adhesive, compressive wraps in the treatment of limb hemangiomas
37. Capillary hemangioma with extensive purpura: Report of a case
38. Infantile orbital hemangiomas
39. Breast cancer after radiotherapy for skin hemangioma in infancy
40. Skin lesions of the spinal axis and spinal dysraphism
41. The role of tranexamic acid in the treatment of giant hemangiomas in newborns
42. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics
43. Vincristine therapy for thrombotic thrombocytopenic purpura
44. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a "beard" distribution
45. Treatment of life-threatening infantile hemangiomas with vincristine
46. Kasabach-Merritt syndrome exacerbated by platelet transfusion
47. The association of facial hemangiomas with Dandy-Walker and other posterior fossa malformations
48. Treatment of hemangiomas of infants with high doses of prednisonde
49. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenom) is associated with kaposiform hemangioendothelioma and not with common infantile hemangioma
50. Giant hemangioendothelioma with associated thrombocytopenia
51. Central retinal artery occlusion associated with periocular corticosteroid injection for juvenile hemangioma
52. Kasabach-Merritt syndrome: Treatment with epsilon-aminocaproic acid and assessment with indium 111 platelet scintigraphy
53. Therapy of Kasabach-Merritt syndrome with cryoprecipitate plus intra-arterial thrombin and aminocaproic acid
54. Cellular markers that distinguish the phases of hemangioma during infancy and childhood
55. Therapeutic efficacy of interferon alfa-2b in infants with life-threatening giant hemangiomas
56. Treatment of recurrent suprahyoid cervicofacial lymphangioma with intravenous cyclophosphamide
57. Kaposiform hemangioendothelioma: An aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy
58. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids
59. Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a
60. Interferon alpha-2a therapy in haemangiomas of infancy: Spastic diplegia as a severe complication